Case Study
Approvals for an Ultra-Rare Hematologic MalignancyRegulatory Submission Strategy and Novel Efficacy Endpoint for Treatment of an Ultra-Rare and ...
Case Study
First Gene Therapy Approved in EuropeVeristat was brought in to create and manage a full development program for a gene therapy for a ...
Case Study
Writing Multiple Marketing Applications At The Same TimeA mid-size pharmaceutical company and its development partner, a small biotechnology company ...
Case Study
Stem Cell Therapy for Stroke PatientsA client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in ...
Case Study
Complex Trial for a Rare Pediatric Gene TherapyA clinical-stage biotechnology start-up asked Veristat to run a new European trial of their complex ...
Case Study
Full Service Support for A Gene Therapy TrialA clinical-stage biotechnology start-up asked Veristat to run complex US and EU trials of their ...
Case Study
Site Monitoring Success With TeamworkImagine you are getting ready to launch the third drug cohort of your early phase clinical trial ...
Case Study
Preparing a New Drug Application (IND)Veristat has collaborated with biopharmaceutical firms on the preparation of over 50 INDs. Learn ...
Case Study
Medical Writing Partnership - IND to NDALearn how the Veristat medical writing team partnered with a sponsor and supported their entire ...